Navigation Links
Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Date:10/31/2013

262.7)(303.0)Restructuring & other special items

(9.6)(18.7)(26.8)(50.8)Adjusted cost of sales

$

864.2$

861.3$

2,566.7$

2,553.5Adjusted gross profit (a)

$

903.2$

940.5$

2,533.9$

2,519.8Adjusted gross margin (a)

51

%52

%50

%50

%Three Months EndedNine Months EndedSeptember 30,September 30,2013201220132012GAAP total operating expenses$

468.7$

458.4$

1,382.1$

1,319.3Deduct:Litigation settlements, net

5.5(8.0)(3.3)2.1Acquisition related costs

(6.3)—(24.8)—Restructuring & other special items

(26.3)(22.5)(78.7)(80.6)Adjusted total operating expenses

$

441.6$

427.9$

1,275.3$

1,240.8Adjusted earnings from operations (b)

$

461.6$

512.6$

1,258.6$

1,279.0Three Months EndedNine Months EndedSeptember 30,September 30,2013201220132012GAAP interest expense$

74.0$

76.1$

233.7$

234.1Deduct:Interest expense related to clean energy investment (c)

(1.9)(1.0)(6.0)(3.9)Non-cash accretion of contingent consideration liability

(8.2)(8.3)(23.9)(24.0)Non-cash interest, primarily amortization of convertible debt discount

(7.6)(5.8)(20.1)(23.3)Adjusted interest expense

$

56.3$

61.0$

183.7$

182.9Three Months EndedNine Months EndedSeptember 30,September 30,2013201220132012GAAP other income (expense)$

(70.6)$

6.2$

(74.4)$

0.6Add:Clean energy investment operating results (c)

5.24.613.112.3Acquisition related costs

3.4—5.1—Financing related costs

63.9—72.6—Restructuring & other special items

16.4—20.71.3Adjusted other income (expense)

$

18.3$

10.8$


'/>"/>
SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
2. Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference
3. Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference
4. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
5. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
6. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
7. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
8. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
9. Mylan to Host Investor Day on Aug. 1, 2013 in New York City
10. Roger Graham Named President of Mylan Specialty
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
(Date:8/29/2014)... 29, 2014 Does your doctor know what you,re ... have recommended marijuana to the over 112,000 currently registered patients ... majority of the other roughly 20,300+ active physicians listed with ... about it – even though a poll in February 2014 ... they have tried it. "With marijuana legalization ...
(Date:8/29/2014)... Aug. 29, 2014   Vittamed Corporation , a neurodiagnostics ... announced today that T. (Teo) Forcht Dagi , MD, ... Board of Directors. " Teo Forcht Dagi ... neurosurgery, medical innovation and venture capital," said Remis Bistras ... to add his clinical, strategic, and entrepreneurial expertise to our ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... Chimerix, Inc., a biotechnology company developing orally-available antiviral ... data for CMX001 in a late-breaker presentation at ... and Chemotherapy (ICAAC, Chicago – September 17-20).   ... Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center ...
... YORK, Sept. 16, 2011 MDC Partners ( ... a majority stake in leading healthcare and pharma ... ( www.concentricpharma.com ).  The partnership with Concentric marks ... growing healthcare marketing sector and positions MDC to ...
Cached Medicine Technology:Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3MDC Partners Launches Integrated Healthcare Marketing Platform With Acquisition of Majority Stake in Concentric Pharma Advertising 2
(Date:8/29/2014)... 2014 A recent article discusses ... a Tokyo clothing store for men with gynecomastia, or male ... or diminishing their problem. Board-certified plastic surgeon Dr. Chasan is ... While many people only associate male breasts with men who ... among men of all ages, often starting in adolescence. Men ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- Astronauts may ... appears to disrupt human immune systems, a new study ... any long missions to asteroids, the moon and Mars ... flu while in space can be dangerous, NASA researchers ... cells in the blood of International Space Station crew ...
(Date:8/29/2014)... TX (PRWEB) August 29, 2014 Carson ... website to provide hearing health care tips to local ... established blog section will offer weekly articles from the ... of topics including the latest advances in hearing restoration ... asked questions. The audiologists plan to write a new ...
(Date:8/29/2014)... trials based on administering antidepressants for acute and ... trials are needed to determine whether these drugs ... regular basis., Dr. Ian Gilron, a professor and ... of Anesthesiology, and his team of seven researchers ... of antidepressants for pain relief post-surgery would work ...
(Date:8/29/2014)... August 29, 2014 The family of ... a series of dialysis treatments has filed a GranuFlo ... was the result of Fresenius Medical Care’s GranuFlo and ... lawsuit, which was file d in Alameda County Superior ... of the products resulted in metabolic alkalosis, a ...
Breaking Medicine News(10 mins):Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Antidepressants show potential for postoperative pain 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4
... first National Women and Girls HIV/AIDS Awareness Day today. ... of the National Institute of Allergy and Infectious Diseases ... said in a press release, “This day of recognition ... HIV/AIDS on women and girls in the United States ...
... a zone in Torun, in northern Poland on the bank of ... Polish vets confirmed the presence of the H5N1 bird flu virus ... the German border but the vets did not confirm whether the ... put by Tadeusz Wijaszka, director of the national laboratory in Pulawy, ...
... WHO, narrowing of the breathing passage, which results due ... biggest killer by 2020. // ,Called ... specific health problems: chronic-obstructive bronchitis and emphysema of the ... narrow due to swelling of the mucous membrane and ...
... denied by the NHS to victims who are suffering the ... saved their day by pitching in. // ,Bupa, ... almost 100 women, who have been diagnosed in the early ... 30 such cases. ,It is estimated that a ...
... not in favor of the rise in Medicare bulk billing, ... // Federal Health Minister Tony Abbott released some alarming statistics ... 75% nationally. ,According to Dr Kim Bulwinkel, from ... to seeing more patients, in order to make it a ...
... Health (OIE) said that the risk of the H5N1 strain ... reported this to the French parliamentary commission on the disease ... risk category. ,It said that the avian flu ... But the Government's chief vet Gardner Murray has rejected the ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: